Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
GBP/USD, GBP/EUR, GBP/JPY, EUR/USD, USD/CNY, DXY
LAND SECURITIES GROUP PLC ORD 10 2/3P, BURFORD CAPITAL LIMITED ORD NPV (DI), SMITH & NEPHEW PLC ORD USD0.20, BIDSTACK GROUP PLC ORD 0.5P, LLOYDS BANKING GROUP PLC ORD 10P, BARCLAYS PLC ORD 25P
FTSE 100, DAX Index, Euro Stoxx 50, S&P 500, Nasdaq Composite, Nikkei 225
Gold, Silver, Crude Oil, Brent Oil, Natural Gas, Bitcoin
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Will Hikma break out after a 5 year H&S pattern,
now that it's making progress in the Covid-19 vaccine business?
Buy Hikma Pharmaceuticals (HIK.L)
Hikma Pharmaceuticals PLC develops, manufactures, and markets pharmaceutical products. The Company offers branded and non-branded generic and in-licensed pharmaceutical products. Hikma Pharmaceuticals serves customers worldwide.
Market Cap: £4.79Billion
The long-term trend on Hikma remains bullish. The corrective move lower...
looking for trend to continue long term
Co. receive good news